Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Corcept May Have Hit Pay Dirt
Motley Fool
Monday, December 27, 2010 - 8:33am
tags:
Corcept Therapeutics, Corlux, Cushing's disease
Incyte: Myelofibrosis Drug Looks Promising
Seeking Alpha
Monday, December 27, 2010 - 8:29am
tags:
Incyte, myelofibrosis
King Pharma resubmits application for pain therapy
Marketwatch
Monday, December 27, 2010 - 8:25am
tags:
King, Remoxy, FDA, oxycodone, Pain Therapeutics
Teva Pharma Rises on Optimism of Reduced Competition for Copaxone MS Drug
Bloomberg
Monday, December 27, 2010 - 8:24am
tags:
Teva Pharmaceuticals, Copaxone, multiple sclerosis, MS, FDA
Alimera Gets Unwelcome Christmas Message From FDA
Seeking Alpha
Monday, December 27, 2010 - 8:22am
tags:
Alimera, FDA, Iluvien, diabetic macular edema
Mylan Agrees to Settle Medicaid Case for $65 Million
Bloomberg
Monday, December 27, 2010 - 8:21am
tags:
Mylan, Medicaid
Confidential Witness: J&J Knew Tylenol Factory Was Failing in 2007
BNET Pharma
Thursday, December 23, 2010 - 9:14am
tags:
JNJ, Tylenol, recalls
Pharma's 2010 legal settlements top $4.5 billion
Fierce Pharma
Thursday, December 23, 2010 - 8:47am
tags:
settlements
Another year of cuts as pharma layoffs hit 50,000
Fierce Pharma
Thursday, December 23, 2010 - 8:46am
tags:
layoffs
Teva May Face Copaxone Copy From Novartis, Momenta as Soon as Next Month
Bloomberg
Thursday, December 23, 2010 - 8:38am
tags:
Teva Pharmaceuticals, Novartis, Copaxone, Momenta, generics, MS, multiple sclerosis
Gilead ends trial of lung disease drug candidate
Yahoo/AP
Thursday, December 23, 2010 - 8:34am
tags:
Gilead Sciences, ambrisenten, IPF, idiopathic pulmonary fibrosis
Arena Completes End-Of-Review Meeting With FDA
Seeking Alpha
Thursday, December 23, 2010 - 8:32am
tags:
FDA, Arena Pharmaceuticals, obesity
Merck's Gardasil wins approval for anal cancer
Reuters
Thursday, December 23, 2010 - 8:27am
tags:
Merck, HPV, anal cancer, Gardasil
Deals to Be Done After AstraZeneca Setback
WSJ Online
Thursday, December 23, 2010 - 8:26am
tags:
AstraZeneca, RSV, Cubist Pharmaceuticals, NanoBio, MicroDose Therapeutx, Novavax, Synagis, motavizumab, Alnylam
Alcoholics May Stop at One Drink With Help From Lundbeck Pill
Bloomberg
Thursday, December 23, 2010 - 8:23am
tags:
alcoholism, Lundbeck, nalmefene
AstraZeneca, Abbott end Certriad license deal
Marketwatch
Wednesday, December 22, 2010 - 9:52pm
tags:
Certriad, AstraZeneca, Abbott Laboratories, dyslipidemia
J&J Overcharged for Medications, AIDS Treatment Group Alleges in Lawsuit
Bloomberg
Wednesday, December 22, 2010 - 9:50pm
tags:
JNJ, AIDS, HIV
Pfizer, Bristol-Myers Blood Thinner Stops Clots Better Than Sanofi Drug
Bloomberg
Wednesday, December 22, 2010 - 9:49pm
tags:
Pfizer, Bristol-Myers Squibb, blood thinners, Apixaban, Lovenox, Sanofi
Novartis says FDA cleared new high blood pressure pill combining Tekturna with 2 older drugs
Yahoo/AP
Wednesday, December 22, 2010 - 9:47pm
tags:
FDA, antihypertensives, Tekturna, Novartis, Amtumide
Will the FDA Be Kind to MannKind?
Motley Fool
Wednesday, December 22, 2010 - 4:36pm
tags:
FDA, MannKind, inhaled insulin, Afrezza

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.